Authors evaluate results of high dose immunoablative therapy with autologous hematopoietic cell support in patients with poor risk multiple sclerosis. Results.
Authors evaluate results of high dose immunoablative therapy with autologous hematopoietic cell support in patients with poor risk multiple sclerosis. Results. (en)